Industry Insight
Information, Observation & Analysis
The H1N1 pandemic is now believed to be a huge threat to society this flu season, and preparations for mass vaccinations are underway
When it comes to halting the chain-reaction spread of influenza, embracing the concept of “herd protection”may be the missing link that helps stop this deadly disease in its tracks.
As nearly obsolete diseases start staging a comeback and potential pandemics loom, it’s time to explore new practice and delivery models to boost vaccination rates across population lines
Human albumin may potentially transform the treatment of stroke and sepsis.
Debilitating illness and death are always tragic, but when disease is preventable by a readily available vaccine, the tragedy begs the questions: Were the affected individuals and their families aware of this vaccine-preventable disease, and was the vaccine required or recommended?
Immune globulin is a standard of care for both FDA-approved and non-FDA-approved indications, and a growing body of research now shows promise for treating other diseases.
Though widespread enough to reach pandemic levels, the H1N1 flu has not yet shown the deadly markings of some past pandemics that have appeared with mild spring beginnings only to return with a virulence in the winter. Is this the ultimate blessing in disguise, affording us the much-needed time for preparedness?
Understanding the shingles virus can help patients dodge this painful and sometimes debilitating condition.